The relationship between urine creatinine levels and statin use primarily involves monitoring for muscle-related toxicity, especially rhabdomyolysis, which is a rare but serious adverse effect of statins.
Creatinine is a waste product from the normal breakdown of muscle tissue.
It's usually excreted in the urine through the kidneys.
Urine creatinine levels help assess kidney function and muscle breakdown.
One of the most dangerous side effects of statins is rhabdomyolysis, where damaged muscle fibers release myoglobin and creatine kinase (CK) into the bloodstream.
➡️ This overwhelms the kidneys and can lead to acute kidney injury (AKI).
➡️ Myoglobin is toxic to kidneys and can lower urine output and change urine color (dark, cola-colored).
Serum CK: 🚀 Elevated (often >10x normal)
Urine myoglobin: Positive (reddish-brown urine)
Urine creatinine:
May drop if kidneys are failing (due to damage)
Creatinine clearance (via 24-hour urine test) may decline
Urine creatinine-to-albumin ratio (UACR) is sometimes used to assess kidney involvement
Parameter | What Happens with Statin-induced Rhabdomyolysis |
---|---|
Urine Creatinine | May decrease if kidney function is impaired |
Serum Creatinine | May increase due to impaired filtration |
Urine Output | Can decrease; urine may appear dark |
Urine Myoglobin | Often elevated (toxic to kidneys) |
Clinical Symptoms | Muscle pain, weakness, fatigue, dark urine |
If a patient on statins presents with:
Unexplained muscle pain or weakness
Dark-colored urine
Fatigue or reduced urine output
👉 Immediately check:
Serum creatinine
Creatine kinase (CK)
Urinalysis (for myoglobin)
Urine creatinine (to assess kidney filtration)